Mesoblast | ApexOnco - Clinical Trials news and analysis

x

“It's very intuitive and always up-to-date”

Monika Vogelmann

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Data insights

24 December 2024

The month ahead: January’s upcoming events

Investors will hope for a JP Morgan buying spree, while readouts could come from Kura, Allogene and MacroGenics.

Regulatory

19 December 2024

Third time lucky for Mesoblast

Subscribe to Mesoblast